Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2025

Global Irritable Bowel Syndrome IBS Treatment Market Report 2024

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2025 – By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2025-2034

Name: Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2025

Proud Members Of

Irritable Bowel Syndrome (IBS) Treatment Market Definition

Irritable bowel syndrome (IBS) treatment refers to the various approaches and interventions aimed at treating gastrointestinal tract disorders, which are frequent disorders that affect the stomach and intestines. It is used to alleviate constipation, diarrhea, and abdominal symptoms, minimize the frequency and severity of flare-ups, and enhance overall well-being.

The main types of irritable bowel syndrome (IBS) treatment drugs are lubiprostone, linaclotide, eluxadoline, rifaximin, alosetron, and others. Lubiprostone is a medication used in the treatment of irritable bowel syndrome (IBS), and it is a selective chloride channel activator that helps to increase fluid secretion in the intestines. The various indications include IBS with constipation, IBS with diarrhea, and IBS with alternating constipation and diarrhea. These are sold through several types of distribution channels, such as hospital pharmacies, online pharmacies, and retail pharmacies, to various end-users, including hospitals, clinics, and home care settings.

Irritable Bowel Syndrome (IBS) Treatment Market Segmentation

The irritable bowel syndrome (IBS) treatment market covered in this report is segmented –

1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs

2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea

3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

4) By End-Users: Hospitals, Clinics, Homecare Settings

Subsegments:

1) By Lubiprostone: Chronic Idiopathic Constipation Treatment, Irritable Bowel Syndrome with Constipation (IBS-C) Treatment

2) By Linaclotide: IBS-C Treatment, Chronic Idiopathic Constipation Treatment

3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment

4) By Rifaximin: IBS-D Treatment, Small Intestinal Bacterial Overgrowth (SIBO) Treatment

5) By Alosetron: Severe IBS-D Treatment for Women

6) By Other Drugs: Prucalopride, Tenapanor, Plecanatide

Irritable Bowel Syndrome (IBS) Treatment Market Size and growth rate 2025 to 2029: Graph

Irritable Bowel Syndrome (IBS) Treatment Market Size 2025 And Growth Rate

The irritable bowel syndrome (IBS) treatment market size has grown rapidly in recent years. It will grow from $2.79 billion in 2024 to $3.07 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of ibs, growing patient awareness, stress and lifestyle factors, patient advocacy and support groups, healthcare reimbursement policies

Irritable Bowel Syndrome (IBS) Treatment Market Growth Forecast

The irritable bowel syndrome (IBS) treatment market size is expected to see rapid growth in the next few years. It will grow to $4.93 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to patient-centric healthcare models, microbial therapies, blockchain in healthcare, patient-reported outcomes (pros), regulatory fast-track programs, health data interoperability. Major trends in the forecast period include integration of digital health solutions, advancements in diagnostic technologies, increased research and development investments, collaborations and partnerships, emergence of non-pharmacological therapies.

Book your 30 minutes free consultation with our research experts

Irritable Bowel Syndrome (IBS) Treatment Market Driver: Irritable Bowel Syndrome (IBS) Treatment Market Grows Amidst Escalating Prevalence

The rise in the prevalence of irritable bowel syndrome (IBS) is expected to propel the growth of the irritable bowel syndrome treatment market going forward. IBS is a chronic gastrointestinal disorder affecting the large intestine (colon). The rise in irritable bowel syndrome (IBS) prevalence is driven by poor lifestyles, bad eating habits, exposure to pollution, and increased stress levels. IBS treatment helps to reduce the severity and frequency of IBS symptoms, improve the quality of life, and enable individuals to manage their conditions better. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD), a US-based non-profit education and research organization, about 5–10% of the global population are having IBS in 2023 and between 25 and 45 million people in the United States are affected by IBS. Therefore, the rise in the prevalence of irritable bowel syndrome (IBS) is driving the growth of the IBS treatment market.

Irritable Bowel Syndrome (IBS) Treatment Market Driver: Surge In Aging Population Fuels Surge In Demand For Ibs Treatment

The aging population is expected to propel the growth of the IBS treatment market going forward. The term aging population refers to a demographic trend characterized by a growing proportion of elderly individuals within a society or population. The aging population uses irritable bowel syndrome (IBS) treatment to manage gastrointestinal symptoms associated with aging, addressing the impact of age-related changes on digestive health and promoting a better quality of life by alleviating discomfort, enhancing digestive function, and supporting overall well-being. For instance, in October 2022, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, the world's population of people aged 60 years and older is growing rapidly, and it is expected to double by 2050 to reach 2.1 billion. Therefore, the aging population is driving the growth of the IBS treatment market.

Global Irritable Bowel Syndrome (IBS) Treatment Market Major Players

Major companies operating in the irritable bowel syndrome (IBS) treatment market include Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Cosmo Technologies Ltd., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc.

Global Irritable Bowel Syndrome (IBS) Treatment Market Trend: Ardelyx Breaks Ground With Ibsrela, A First-In-Class Treatment For Irritable Bowel Syndrome With Constipation (IBS-C)

Product innovations have emerged as a key trend gaining popularity in the irritable bowel syndrome (IBS) market. Major irritable bowel syndrome (IBS) market players are concentrating their efforts on creating new and innovative, advanced products to strengthen their position in the market. For instance, in April 2022, Ardelyx, a US-based biotechnology company, launched IBSRELA, a first-in-class treatment for IBS-C in adults. It is the first and only NHE3 inhibitor available for treating adult irritable bowel syndrome with constipation (IBS-C). IBSRELA, the first Ardelyx medicine to receive FDA approval, is the first novel mechanism therapy for IBS-C (irritable bowel syndrome-constipation) to be developed in almost ten years, and it provides a significant new treatment option for constipation, bloating, and stomach pain that are symptoms of this crippling disorder.

Global Irritable Bowel Syndrome (IBS) Treatment Market Trend: Sanofi And Teva Join Forces In Strategic Partnership To Advance Treatment Solutions

Major companies operating in the irritable bowel syndrome (IBS) market are adopting a strategic partnership approach to treating Crohn's disease and ulcerative colitis. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2023, Sanofi S.A., a France-based pharmaceutical industry company, partnered with Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company. With this partnership, they aim to deliver treatment for inflammatory bowel disease.

Irritable Bowel Syndrome (IBS) Treatment Market Merger And Acquisition: Roche Acquires Telavant Holdings To Expand Presence In Ibs Treatment Market

In October 2023, Roche, a Switzerland-based healthcare company acquired Telavant Holdings for an undisclosed amount. Through the acquisition, Roche will obtain the rights to develop, manufacture, and market a novel treatment for Irritable Bowel Syndrome (IBS) in the United States and Japan. Telavant Holdings is a US-based biotechnology company focusing on the development and commercialization of innovative therapies for inflammatory and fibrotic diseases.

Regional Outlook For The Global Irritable Bowel Syndrome (IBS) Treatment Market

North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (IBS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the irritable bowel syndrome (IBS) treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Irritable Bowel Syndrome (IBS) Treatment Market?

The irritable bowel syndrome (IBS) treatment market includes revenues earned by entities by providing services such as consultation, cognitive-behavioral therapy (CBT), hypnotherapy, psychological therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The irritable bowel syndrome (IBS) market also includes sales of antispasmodics, fiber supplements, laxatives, probiotics, and certain medications targeting gut function. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Irritable Bowel Syndrome (IBS) Treatment Industry?

The irritable bowel syndrome (IBS) treatment market research report is one of a series of new reports from The Business Research Company that provides irritable bowel syndrome (IBS) treatment market statistics, including irritable bowel syndrome (IBS) treatment industry global market size, regional shares, competitors with an irritable bowel syndrome (IBS) treatment market share, detailed irritable bowel syndrome (IBS) treatment market segments, market trends and opportunities, and any further data you may need to thrive in the irritable bowel syndrome (IBS) treatment industry. This irritable bowel syndrome (IBS) treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Irritable Bowel Syndrome (IBS) Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.07 billion
Revenue Forecast In 2034	$4.93 billion
Growth Rate	CAGR of 12.5% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs 2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea 3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies 4) By End-Users: Hospitals, Clinics, Homecare Settings Subsegments: 1) By Lubiprostone: Chronic Idiopathic Constipation Treatment, Irritable Bowel Syndrome with Constipation (IBS-C) Treatment 2) By Linaclotide: IBS-C Treatment, Chronic Idiopathic Constipation Treatment 3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment 4) By Rifaximin: IBS-D Treatment, Small Intestinal Bacterial Overgrowth (SIBO) Treatment 5) By Alosetron: Severe IBS-D Treatment for Women 6) By Other Drugs: Prucalopride, Tenapanor, Plecanatide
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Cosmo Technologies Ltd., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Irritable Bowel Syndrome (IBS) Treatment Market Characteristics

3. Irritable Bowel Syndrome (IBS) Treatment Market Trends And Strategies

4. Irritable Bowel Syndrome (IBS) Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Irritable Bowel Syndrome (IBS) Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Irritable Bowel Syndrome (IBS) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Irritable Bowel Syndrome (IBS) Treatment Market Growth Rate Analysis

5.4. Global Irritable Bowel Syndrome (IBS) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Irritable Bowel Syndrome (IBS) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Irritable Bowel Syndrome (IBS) Treatment Total Addressable Market (TAM)

6. Irritable Bowel Syndrome (IBS) Treatment Market Segmentation

6.1. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lubiprostone

Linaclotide

Eluxadoline

Rifaximin

Alosetron

Other Drugs

6.2. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IBS With Constipation

IBS With Diarrhea

IBS With Alternating Constipation And Diarrhea

6.3. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

6.4. Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Homecare Settings

6.5. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Lubiprostone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Idiopathic Constipation Treatment

Irritable Bowel Syndrome with Constipation (IBS-C) Treatment

6.6. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IBS-C Treatment

Chronic Idiopathic Constipation Treatment

6.7. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Eluxadoline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IBS with Diarrhea (IBS-D) Treatment

6.8. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Rifaximin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IBS-D Treatment

Small Intestinal Bacterial Overgrowth (SIBO) Treatment

6.9. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Alosetron, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Severe IBS-D Treatment for Women

6.10. Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prucalopride

Tenapanor

Plecanatide

7. Irritable Bowel Syndrome (IBS) Treatment Market Regional And Country Analysis

7.1. Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market

8.1. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Irritable Bowel Syndrome (IBS) Treatment Market

9.1. China Irritable Bowel Syndrome (IBS) Treatment Market Overview

9.2. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Irritable Bowel Syndrome (IBS) Treatment Market

10.1. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Irritable Bowel Syndrome (IBS) Treatment Market

11.1. Japan Irritable Bowel Syndrome (IBS) Treatment Market Overview

11.2. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Irritable Bowel Syndrome (IBS) Treatment Market

12.1. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market

13.1. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Irritable Bowel Syndrome (IBS) Treatment Market

14.1. South Korea Irritable Bowel Syndrome (IBS) Treatment Market Overview

14.2. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market

15.1. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market Overview

15.2. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Irritable Bowel Syndrome (IBS) Treatment Market

16.1. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Irritable Bowel Syndrome (IBS) Treatment Market

17.1. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Irritable Bowel Syndrome (IBS) Treatment Market

18.1. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Irritable Bowel Syndrome (IBS) Treatment Market

19.1. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Irritable Bowel Syndrome (IBS) Treatment Market

20.1. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market

21.1. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market Overview

21.2. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Irritable Bowel Syndrome (IBS) Treatment Market

22.1. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Irritable Bowel Syndrome (IBS) Treatment Market

23.1. North America Irritable Bowel Syndrome (IBS) Treatment Market Overview

23.2. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Irritable Bowel Syndrome (IBS) Treatment Market

24.1. USA Irritable Bowel Syndrome (IBS) Treatment Market Overview

24.2. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Irritable Bowel Syndrome (IBS) Treatment Market

25.1. Canada Irritable Bowel Syndrome (IBS) Treatment Market Overview

25.2. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Irritable Bowel Syndrome (IBS) Treatment Market

26.1. South America Irritable Bowel Syndrome (IBS) Treatment Market Overview

26.2. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Irritable Bowel Syndrome (IBS) Treatment Market

27.1. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Irritable Bowel Syndrome (IBS) Treatment Market

28.1. Middle East Irritable Bowel Syndrome (IBS) Treatment Market Overview

28.2. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Irritable Bowel Syndrome (IBS) Treatment Market

29.1. Africa Irritable Bowel Syndrome (IBS) Treatment Market Overview

29.2. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Irritable Bowel Syndrome (IBS) Treatment Market Competitive Landscape And Company Profiles

30.1. Irritable Bowel Syndrome (IBS) Treatment Market Competitive Landscape

30.2. Irritable Bowel Syndrome (IBS) Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Irritable Bowel Syndrome (IBS) Treatment Market Other Major And Innovative Companies

31.1. Abbott Laboratories

31.2. Takeda Pharmaceutical Company Limited

31.3. Eli Lilly and Company

31.4. Amgen Inc.

31.5. Astellas Pharma Inc.

31.6. Biogen Inc.

31.7. Bausch Health Companies Inc.

31.8. Ironwood Pharmaceuticals Inc.

31.9. Sebela Pharmaceuticals Inc.

31.10. Prometheus Laboratories Inc.

31.11. RedHill Biopharma Ltd.

31.12. Ardelyx Inc.

31.13. Cosmo Technologies Ltd.

31.14. Renexxion Ireland Ltd.

31.15. 4D Pharma plc

32. Global Irritable Bowel Syndrome (IBS) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Irritable Bowel Syndrome (IBS) Treatment Market

34. Recent Developments In The Irritable Bowel Syndrome (IBS) Treatment Market

35. Irritable Bowel Syndrome (IBS) Treatment Market High Potential Countries, Segments and Strategies

35.1 Irritable Bowel Syndrome (IBS) Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Irritable Bowel Syndrome (IBS) Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Irritable Bowel Syndrome (IBS) Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Lubiprostone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Eluxadoline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Rifaximin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Alosetron, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: Pfizer Inc. Financial Performance

Table 82: Johnson & Johnson Services Inc. Financial Performance

Table 83: AbbVie Inc. Financial Performance

Table 84: Novartis AG Financial Performance

Table 85: AstraZeneca plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Lubiprostone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Linaclotide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Eluxadoline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Rifaximin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Alosetron, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Irritable Bowel Syndrome (IBS) Treatment Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Irritable Bowel Syndrome (IBS) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Irritable Bowel Syndrome (IBS) Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: Pfizer Inc. Financial Performance

Figure 82: Johnson & Johnson Services Inc. Financial Performance

Figure 83: AbbVie Inc. Financial Performance

Figure 84: Novartis AG Financial Performance

Figure 85: AstraZeneca plc Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Aerospace Composites Global Market Report 2025 – By Fiber Type (Carbon Fiber Composites, Ceramic Fiber Composites, Glass Fiber Composites, Others), By Aircraft Type (Commercial Aircraft, Business & General Aviation, Civil Helicopter, Military Aircraft, Others), By Manufacturing Process (AFP/ATL, Lay-Up Process, Resin Transfer Molding Process, Filament Winding Process, Others), By Resin Type (Benzoxazine, Cyanate Ester, Bismalimide, Ceramic and Metal Matrix, Thermosetting Resins, Polyester, Others), By Application (Interior, Exterior) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Fasteners Global Market Report 2025 – By Product (Screws, Nuts and Bolts, Washers, Rivets), By Platform (Fixed Wing Aircraft, Rotary Wing Aircraft), By Material (Aluminum, Titanium, Alloy Steel), By End-Use (Commercial, Defense) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Foams Global Market Report 2025 – By Product (Polyurethane, Polyimide, Metal Foams, Melamine, Polyethylene, Other Products), By Application (Aircraft Seats, Aircraft Floor Carpets, Cabin Walls and Ceilings, Flight Deck Pads, Overhead Stow Bins, Other Applications), By End-Use (General Aviation, Commercial Aviation, Military Aircraft) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Plastics Global Market Report 2025 – By Polymer Type (Polyether Ether Ketone (PEEK), Polymethyl Methacrylate (PMMA), Polycarbonates (PC), Polyphenylene Sulfide (PPS), Acrylonitrile Butadiene Styrene (ABS)), By Application (Aircraft Frame, Components, Cabin Interiors, Wings And Rotor Blades, Other Applications), By End-use (Commercial Aircrafts, Military Aircrafts, Rotary Aircrafts, General Aviation) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Interior Adhesive Global Market Report 2025 – By Resin Type (Epoxy, Polyurethane, Acrylic, Cyanoacrylate, Other Types ), By Aircraft Type (Single Aisle, Small Wide Body, Medium Wide Body, Large Wide Body, Regional Jets), By Application Type (Seats, Inflight entertainment, Lavatory, Interior panels, Galley, Stowage bins, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Tapes Global Market Report 2025 – By Resin Type (Acrylic, Rubber, Silicone, Other Resin Types ), By Backing Material (Paper/Tissue, Film, Foam, Other Backing Material ), By End User (Commercial Aviation, Military Aviation, General Aviation) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Coatings Global Market Report 2025 – By Product Type (Top-Coat, Primer, Other Product Types ), By Resin (Epoxy, Polyurethane, Acrylic, Other Resins), By Technology (Solvent-Based Coatings, Water-Based Coatings, Powder Coatings, Other Technologies), By Application (Exterior, Interior ), By End User (Commercial Aviation, Military Aviation, General Aviation, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Aerospace Valves Global Market Report 2025 – By Type (Butterfly Valves, Rotary Valves, Solenoid Valves, Flapper-nozzle Valves, Poppet Valves, Gate Valves, Ball Valves, Other Types), By Material (Stainless Steel, Titanium, Aluminum, Other Materials), By Application (Fuel System, Hydraulic System, Environmental Control System, Pneumatic System, Lubrication System, Water & Wastewater System), By End Use (OEM, Aftermarket) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Irritable Bowel Syndrome (IBS) Treatment market?

How will the Irritable Bowel Syndrome (IBS) Treatment market drivers and restraints affect the market dynamics? What forces will shape the Irritable Bowel Syndrome (IBS) Treatment industry going forward?

The Irritable Bowel Syndrome (IBS) Treatment market major growth driver - Irritable Bowel Syndrome (IBS) Treatment Market Grows Amidst Escalating Prevalence. For further insights on the Irritable Bowel Syndrome (IBS) Treatment market, request a sample here

What is the forecast market size or the forecast market value of the Irritable Bowel Syndrome (IBS) Treatment market?

The Irritable Bowel Syndrome (IBS) Treatment market size has grown strongly in recent years. The irritable bowel syndrome (IBS) treatment market size has grown rapidly in recent years. It will grow from $2.79 billion in 2024 to $3.07 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of ibs, growing patient awareness, stress and lifestyle factors, patient advocacy and support groups, healthcare reimbursement policies The irritable bowel syndrome (IBS) treatment market size is expected to see rapid growth in the next few years. It will grow to $4.93 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to patient-centric healthcare models, microbial therapies, blockchain in healthcare, patient-reported outcomes (pros), regulatory fast-track programs, health data interoperability. Major trends in the forecast period include integration of digital health solutions, advancements in diagnostic technologies, increased research and development investments, collaborations and partnerships, emergence of non-pharmacological therapies. For further insights on the Irritable Bowel Syndrome (IBS) Treatment market, request a sample here

How is the Irritable Bowel Syndrome (IBS) Treatment market segmented?

The irritable bowel syndrome (IBS) treatment market covered in this report is segmented –
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs
2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Users: Hospitals, Clinics, Homecare Settings Subsegments:
1) By Lubiprostone: Chronic Idiopathic Constipation Treatment, Irritable Bowel Syndrome with Constipation (IBS-C) Treatment
2) By Linaclotide: IBS-C Treatment, Chronic Idiopathic Constipation Treatment
3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment
4) By Rifaximin: IBS-D Treatment, Small Intestinal Bacterial Overgrowth (SIBO) Treatment
5) By Alosetron: Severe IBS-D Treatment for Women
6) By Other Drugs: Prucalopride, Tenapanor, Plecanatide For further insights on the Irritable Bowel Syndrome (IBS) Treatment market, request a sample here

Which region has the largest share of the Irritable Bowel Syndrome (IBS) Treatment market? What are the other regions covered in the report?

North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (IBS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Irritable Bowel Syndrome (IBS) Treatment market, request a sample here.

Who are the major players in the Irritable Bowel Syndrome (IBS) Treatment market?

What are the key trends in the Irritable Bowel Syndrome (IBS) Treatment market?

Major trends in the Irritable Bowel Syndrome (IBS) Treatment market include Ardelyx Breaks Ground With Ibsrela, A First-In-Class Treatment For Irritable Bowel Syndrome With Constipation (IBS-C). For further insights on the Irritable Bowel Syndrome (IBS) Treatment market, request a sample here.

What are the major opportunities in the Irritable Bowel Syndrome (IBS) Treatment market? What are the strategies for the Irritable Bowel Syndrome (IBS) Treatment market?

For detailed insights on the major opportunities and strategies in the Irritable Bowel Syndrome (IBS) Treatment market, request a sample here.

How does the Irritable Bowel Syndrome (IBS) Treatment market relate to the overall economy and other similar markets?

For detailed insights on Irritable Bowel Syndrome (IBS) Treatment's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Irritable Bowel Syndrome (IBS) Treatment industry?

For detailed insights on the mergers and acquisitions in the Irritable Bowel Syndrome (IBS) Treatment industry, request a sample here.

What are the key dynamics influencing the Irritable Bowel Syndrome (IBS) Treatment market growth? SWOT analysis of the Irritable Bowel Syndrome (IBS) Treatment market.

For detailed insights on the key dynamics influencing the Irritable Bowel Syndrome (IBS) Treatment market growth and SWOT analysis of the Irritable Bowel Syndrome (IBS) Treatment industry, request a sample here.